Skip to main content

Table 1 Clinical and genetic data of carefully selected neuroblastoma samples that were included in this study

From: Erratum to: Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes

Sample number Lab number % Tumor cells Stage MYCN amp Ploidy Adrenal localization Age Dead/alive Overall survival (months) Type
NB1 98T33 95 1 No Tri Yes < 1 year Alive 76.9 Favorable
NB2 99T84 90 1 No Tri No < 1 year Alive 71.8 Favorable
NB3 96T82 90 1 No Tri Yes < 1 year Alive 115.5 Favorable
NB4 99T129 90 1 No Tri Yes < 1 year Alive 71.7 Favorable
NB5 01T28 90 4 Yes Di Yes > 1 year Dead 5.6 Unfavorable
NB6 03T304 100 3* No Di Abdominal > 1 year Alive 12.0 Unfavorable
NB7 03T236 90 4 No ND Yes > 5 year Dead 19.4 Unfavorable
NB8 00T54 70 1 No Tri Yes < 1 year Alive 62.6 Favorable
NB9 00T35 >95 4 Yes Di Yes < 1 year Dead 13.7 Unfavorable
NB10 99T125 80 3 No Di Yes > 5 year Alive 79.3 Unfavorable
NB11 = NB4 99T129 90 1 No Tri Yes < 1 year Alive 71.7 Favorable
NB12 02T192 100 4 Yes Di Abdominal > 5 year Dead 16.2 Unfavorable
NB13 D031 >95 4 No Di Abdominal > 1 year Dead 64.8 Unfavorable
NB14 E002 >80 4 No ND Abdominal > 1 year Alive 65.7 Unfavorable
NB15 E037 >80 4 No ND Abdominal > 1 year Alive 45.3 Unfavorable
NB16 E044 >80 4 No ND Yes < 1 year Alive 37.0 Unfavorable
NB17 E121 >80 4 Yes ND Abdominal > 1 year Dead 78.4 Unfavorable
NB18 04T121 60 3 Yes Di Yes > 1 year Dead 6 Unfavorable
  1. Samples were subdivided into favorable or unfavorable type based on MYCN amplification, ploidy and age at diagnosis. *Neuroblastoma or nodular gan-glioneuroblastoma. ND, not determined or unknown.